BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34764205)

  • 1. The Protein Kinase Activity of NME7 Activates Wnt/β-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma.
    Ren X; Rong Z; Liu X; Gao J; Xu X; Zi Y; Mu Y; Guan Y; Cao Z; Zhang Y; Zeng Z; Fan Q; Wang X; Pei Q; Wang X; Xin H; Li Z; Nie Y; Qiu Z; Li N; Sun L; Deng Y
    Cancer Res; 2022 Jan; 82(1):60-74. PubMed ID: 34764205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway.
    Lou YX; Gu J; Zhu L; Sun SQ; Hao XL; Chen JP; Han F; Wang DD; Jiang X; Liu JY
    Lab Invest; 2023 Dec; 103(12):100260. PubMed ID: 37839635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signaling pathway in liver biology and tumorigenesis.
    Matsumoto S; Kikuchi A
    In Vitro Cell Dev Biol Anim; 2024 May; 60(5):466-481. PubMed ID: 38379098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axis.
    Li Z; Caron de Fromentel C; Kim W; Wang WH; Sun J; Yan B; Utturkar S; Lanman NA; Elzey BD; Yeo Y; Zhang H; Kazemian M; Levrero M; Andrisani O
    Cell Death Dis; 2023 Nov; 14(11):786. PubMed ID: 38036507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILKAP Promotes the Metastasis of Hepatocellular Carcinoma Cells by Inhibiting β-Catenin Degradation and Enhancing the WNT Signaling Pathway.
    Zhang R; Yuan J; Liu S; Torraca V; Liao Z; Wu Y; Tan H; Yao X; Hou X; Lyu H; Xiao S; Guo D; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
    Adv Biol (Weinh); 2024 May; 8(5):e2300117. PubMed ID: 38379270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway.
    Bi Y; Zhang L; Song Y; Sun L; Mulholland MW; Yin Y; Zhang W
    Gastroenterol Hepatol; 2024 Apr; 47(4):352-365. PubMed ID: 37437654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting WNT/β-Catenin via Modulating EZH2 Function: A New Chapter in the Treatment of β-Catenin Mutant Hepatocellular Carcinoma?
    Hung MH; Wang XW
    Cancer Res; 2023 Nov; 83(21):3498-3500. PubMed ID: 37747420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation.
    Liu M; Jiang K; Lin G; Liu P; Yan Y; Ye T; Yao G; Barr MP; Liang D; Wang Y; Gong P; Meng S; Piao H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):165. PubMed ID: 30041665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma.
    Li J; Tuo D; Guo G; Gan J
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15763-15779. PubMed ID: 37668796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
    Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
    Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β-catenin signaling and tumor growth.
    Azbazdar Y; Demirci Y; Heger G; Ipekgil D; Karabicici M; Ozhan G
    Mol Oncol; 2023 Nov; 17(11):2314-2336. PubMed ID: 37699867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of peroxiredoxin 2 suppresses proliferation and Wnt/β-catenin pathway, and induces senescence in hepatocellular carcinoma.
    Yang X; Xiang X; Xu G; Zhou S; An T; Huang Z
    Oncol Res; 2023; 32(1):213-226. PubMed ID: 38188679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
    Wang Y; Cheng C; Lu Y; Lian Z; Liu Q; Xu Y; Li Y; Li H; Zhang L; Jiang X; Li B; Yu D
    Cancer Res; 2024 May; 84(10):1643-1658. PubMed ID: 38417136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
    Wang K; Wu J; Yang Z; Zheng B; Shen S; Wang RR; Zhang Y; Wang HY; Chen L; Qiu X
    Cancer Lett; 2024 Apr; 586():216690. PubMed ID: 38307410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β-catenin pathway.
    Li S; Wang J; Chen H; Hou J; Shen T; Li J; Zhou B; Zhang B; Liu H; Jiang DK
    Mol Carcinog; 2023 Nov; 62(11):1686-1699. PubMed ID: 37477507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of FAM83F by c-Myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
    Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
    Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallic acid promotes ferroptosis in hepatocellular carcinoma via inactivating Wnt/β-catenin signaling pathway.
    Xie J; Wang H; Xie W; Liu Y; Chen Y
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2437-2445. PubMed ID: 37847411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells.
    Long G; Wu Z; Wang D; Mi X; Hu K; Zhou L; Tang J
    Free Radic Biol Med; 2024 Feb; 212():162-173. PubMed ID: 38092274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA 5-methylcytosine writer NSUN5 promotes hepatocellular carcinoma cell proliferation via a ZBED3-dependent mechanism.
    Gu X; Li P; Gao X; Ru Y; Xue C; Zhang S; Liu Y; Hu X
    Oncogene; 2024 Feb; 43(9):624-635. PubMed ID: 38182896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma.
    Shi CJ; Lv MY; Deng LQ; Zeng WQ; Fu WM; Zhang JF
    Cell Biol Toxicol; 2023 Aug; 39(4):1735-1752. PubMed ID: 36576707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.